389 related articles for article (PubMed ID: 20930310)
1. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
[TBL] [Abstract][Full Text] [Related]
2. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
3. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
[TBL] [Abstract][Full Text] [Related]
4. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
Denollet J; Vrints CJ; Conraads VM
Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
[TBL] [Abstract][Full Text] [Related]
6. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
7. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression.
Diniz BS; Teixeira AL; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Psychiatr Res; 2010 Oct; 44(14):917-20. PubMed ID: 20338581
[TBL] [Abstract][Full Text] [Related]
8. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
[TBL] [Abstract][Full Text] [Related]
9. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease.
Barabash A; Marcos A; Ancín I; Vázquez-Alvarez B; de Ugarte C; Gil P; Fernández C; Encinas M; López-Ibor JJ; Cabranes JA
Neurobiol Aging; 2009 Aug; 30(8):1254-64. PubMed ID: 18078695
[TBL] [Abstract][Full Text] [Related]
10. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.
Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
Immunol Lett; 2008 May; 117(2):198-202. PubMed ID: 18367253
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
Popp J; Bacher M; Kölsch H; Noelker C; Deuster O; Dodel R; Jessen F
J Psychiatr Res; 2009 May; 43(8):749-53. PubMed ID: 19038405
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
Buchhave P; Janciauskiene S; Zetterberg H; Blennow K; Minthon L; Hansson O
Neurosci Lett; 2009 Jan; 450(1):56-9. PubMed ID: 18996438
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
[TBL] [Abstract][Full Text] [Related]
14. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.
Denollet J; Schiffer AA; Kwaijtaal M; Hooijkaas H; Hendriks EH; Widdershoven JW; Kupper N
Am J Cardiol; 2009 Feb; 103(3):399-404. PubMed ID: 19166697
[TBL] [Abstract][Full Text] [Related]
16. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
[TBL] [Abstract][Full Text] [Related]
17. Association between serum soluble TNFα receptors and renal dysfunction in type 2 diabetic patients without proteinuria.
Miyazawa I; Araki S; Obata T; Yoshizaki T; Morino K; Kadota A; Ugi S; Kawai H; Uzu T; Nishio Y; Koya D; Haneda M; Kashiwagi A; Maegawa H
Diabetes Res Clin Pract; 2011 May; 92(2):174-80. PubMed ID: 21288590
[TBL] [Abstract][Full Text] [Related]
18. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
19. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.
Alvarez A; Cacabelos R; Sanpedro C; García-Fantini M; Aleixandre M
Neurobiol Aging; 2007 Apr; 28(4):533-6. PubMed ID: 16569464
[TBL] [Abstract][Full Text] [Related]
20. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
